Another study published by Diabetes, Obesity & Metabolism in June 2025 further supported this link, concluding that the five-year risk of developing NAION doubled in patients using GLP-1 drugs compared to non-users
Sulfur burps and other GI side effects can make eating sufficient protein difficult, accelerating lean mass loss
Seales de advertencia: Busque atencin mdica inmediata si experimenta dolor abdominal severo y persistente, vmitos que impiden la hidratacin, sangre en las heces, o signos de deshidratacin (mareos, orina oscura, confusin)
Having said that, other people may gain weight quickly because of change in diet, or they develop a disability and their physical activity goes down, or they're on a weight-gaining drug for diabetes or something they can have rapid risk as well
Diarrhea does not rule out another gastrointestinal problem
Because the prevalence of CVD in the population with T2DM is around 32% [33], at least one fourth of the average patient with T2DM is possible a candidate for the use of the GLP-1RA, or sodium-glucose transporter-2 inhibitors [34], to improve the MACE outcome
